Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
28 Nov 2023
28 Nov 2023
Historique:
accepted:
21
08
2023
received:
09
01
2023
medline:
27
11
2023
pubmed:
25
9
2023
entrez:
25
9
2023
Statut:
ppublish
Résumé
Acute kidney injury (AKI) is a frequent complication of allogeneic hematopoietic cell transplantation (allo-HCT). There are many causes of AKI after allo-HCT, but it is unknown whether renal acute graft-versus-host disease (aGVHD) caused by direct allogeneic donor T-cell-mediated renal damage contributes. Here, we tested whether allogeneic donor T cells attack kidneys in murine models of aGVHD. To avoid confounding effects of nephrotoxic agents, we did not administer immunosuppressants for GVHD prophylaxis. We found that urinary N-acetyl-β-D-glucosaminidase, a marker of tubular injury, was elevated in allogeneic recipients on day 14 after allogeneic bone marrow transplantation. Donor major histocompatibility complex-positive cells were present and CD3+ T cells were increased in the glomerulus, peritubular capillaries, interstitium, and perivascular areas in the kidneys of allo-HCT recipient mice. These T cells included both CD4+ and CD8+ cells with elevated activation markers, increased exhaustion markers, and greater secretion of proinflammatory cytokines and cytotoxic proteins. Consistent with allo-T-cell-mediated renal damage, expression of neutrophil gelatinase-binding lipocalin, a marker of AKI, and elafin, a marker of aGVHD, were increased in renal tissue of allogeneic recipients. Because apoptosis of target cells is observed on histopathology of aGVHD target tissues, we confirmed that alloreactive T cells increased apoptosis of renal endothelial and tubular epithelial cells in cytotoxic T-lymphocyte assays. These data suggest that immune responses induced by donor T cells contribute to renal endothelial and tubular epithelial cell injury in allo-HCT recipients and that aGVHD may contribute to AKI after allo-HCT.
Identifiants
pubmed: 37748044
pii: 498046
doi: 10.1182/bloodadvances.2023009721
pmc: PMC10690563
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6936-6948Subventions
Organisme : NHLBI NIH HHS
ID : K08 HL157619
Pays : United States
Informations de copyright
© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Références
Lancet. 2009 May 2;373(9674):1550-61
pubmed: 19282026
QJM. 2020 Sep 1;113(9):621-632
pubmed: 32101318
Nat Microbiol. 2019 May;4(5):800-812
pubmed: 30858572
Blood. 2011 Jul 7;118(1):192-204
pubmed: 21471527
Biol Blood Marrow Transplant. 2012 Aug;18(8):1150-63
pubmed: 22510384
Sci Transl Med. 2010 Jan 6;2(13):13ra2
pubmed: 20371463
Biol Blood Marrow Transplant. 2015 Apr;21(4):589-603
pubmed: 25639770
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Nat Rev Nephrol. 2019 Apr;15(4):220-239
pubmed: 30651611
N Engl J Med. 2016 Jun 9;374(23):2256-67
pubmed: 27276563
Am J Transplant. 2020 Sep;20(9):2318-2331
pubmed: 32463180
Clin Exp Immunol. 2018 May;192(2):142-150
pubmed: 29453850
J Nippon Med Sch. 2020 Mar 11;87(1):7-12
pubmed: 31776318
Hypertension. 2020 Dec;76(6):1868-1878
pubmed: 33131309
Biol Blood Marrow Transplant. 2008 Jan;14(1):125-31
pubmed: 18158969
Am J Clin Pathol. 2016 May;145(5):591-603
pubmed: 27247365
Bone Marrow Transplant. 2016 Jun;51(6):755-62
pubmed: 26855155
N Engl J Med. 2017 Nov 30;377(22):2167-2179
pubmed: 29171820
Front Immunol. 2022 Jan 04;12:779881
pubmed: 35058924
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):12-20
pubmed: 25388519
Cell Transplant. 2017 Aug;26(8):1428-1440
pubmed: 28901194
Best Pract Res Clin Haematol. 2008 Jun;21(2):139-48
pubmed: 18503982
Bone Marrow Transplant. 2010 Jan;45(1):153-8
pubmed: 19430501
PLoS One. 2014 Dec 26;9(12):e115399
pubmed: 25541735
Biol Blood Marrow Transplant. 2009 Jan;15(1):21-9
pubmed: 19135939
Bone Marrow Transplant. 2006 Sep;38(5):351-7
pubmed: 16862167
Blood. 2017 Mar 30;129(13):1747-1752
pubmed: 28153825
Transplant Cell Ther. 2021 Feb;27(2):115-124
pubmed: 33017661
Biol Blood Marrow Transplant. 2019 Oct;25(10):1920-1924
pubmed: 31271886
Blood. 2012 Apr 19;119(16):3844-53
pubmed: 22101894
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):289-297
pubmed: 31836598
Am J Transplant. 2014 Feb;14(2):255-71
pubmed: 24401076
Biochem Soc Trans. 2011 Oct;39(5):1450-4
pubmed: 21936832
Blood. 1996 Oct 15;88(8):3230-9
pubmed: 8963063
Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508
pubmed: 19218475
Intern Med. 2012;51(16):2105-10
pubmed: 22892486
Lancet Haematol. 2020 Feb;7(2):e157-e167
pubmed: 32004485
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1
pubmed: 25529383
Biol Blood Marrow Transplant. 2018 Mar;24(3):571-580
pubmed: 29155318
Blood. 2021 Dec 2;138(22):2165-2172
pubmed: 34482399
Nat Med. 2005 Nov;11(11):1244-9
pubmed: 16227991
Blood. 2013 May 16;121(20):4231-41
pubmed: 23520337